Staying on the cutting edge of oncology advances

Rapidly-changing treatment landscapes in diseases like lung cancer pose challenges for medical education providers, who need to be more adaptable than ever. Medscape’s Katie Lucero tells us about the needs of modern healthcare professionals and how a more personalised online approach to education could help them navigate a complex environment.

Sometimes it can feel as if cancer treatment goes through a paradigm shift every few months – and that feeling is perhaps most acute in lung cancer, which has seen advances in recent years that have transformed this once almost-untreatable disease into one where patients can have real hope.

Treatment for lung cancer already varies widely depending upon the type of cancer (small cell or non-small cell) and its stage. The new, innovative therapies emerging every year – from precision, biomarker-specific medicines to immunotherapy and gene therapy – only add to this complexity.

With so many developments coming so rapidly, it is more important than ever – but also more difficult – for oncologists to stay current with the latest information on how to achieve the best outcomes for patients.
• Read the full article in pharmaphorum’s Deep Dive digital magazine